| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Qinghai Spring Medicinal Resources Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.47 |
| 52 Week High | CN¥9.87 |
| 52 Week Low | CN¥1.84 |
| Beta | 0.46 |
| 11 Month Change | 64.46% |
| 3 Month Change | -23.57% |
| 1 Year Change | -64.26% |
| 33 Year Change | -59.46% |
| 5 Year Change | -35.74% |
| Change since IPO | -87.91% |
Recent News & Updates
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump
Jun 24
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues
May 09Recent updates
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) Share Price Is Still Matching Investor Opinion Despite 30% Slump
Jun 24Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 26% Cheaper Price Remains In Tune With Revenues
May 09Qinghai Spring Medicinal Resources Technology Co., Ltd.'s (SHSE:600381) 27% Price Boost Is Out Of Tune With Revenues
Mar 12Shareholder Returns
| 600381 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 15.7% | 2.5% | 3.3% |
| 1Y | -64.3% | -12.2% | -19.1% |
Return vs Industry: 600381 underperformed the CN Pharmaceuticals industry which returned -12.2% over the past year.
Return vs Market: 600381 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
| 600381 volatility | |
|---|---|
| 600381 Average Weekly Movement | 9.5% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 600381's share price has been volatile over the past 3 months.
Volatility Over Time: 600381's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 173 | Xuefeng Zhang | www.verygrass.com |
Qinghai Spring Medicinal Resources Technology Co., Ltd. research and development, production, and sale of cordyceps products. It is also involved in the sale of beverages and aquatic products; advertising; and foreign investment business.
Qinghai Spring Medicinal Resources Technology Co., Ltd. Fundamentals Summary
| 600381 fundamental statistics | |
|---|---|
| Market cap | CN¥1.94b |
| Earnings (TTM) | -CN¥266.05m |
| Revenue (TTM) | CN¥242.03m |
8.4x
P/S Ratio-7.7x
P/E RatioIs 600381 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600381 income statement (TTM) | |
|---|---|
| Revenue | CN¥242.03m |
| Cost of Revenue | CN¥103.66m |
| Gross Profit | CN¥138.37m |
| Other Expenses | CN¥404.42m |
| Earnings | -CN¥266.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 02, 2024
| Earnings per share (EPS) | -0.45 |
| Gross Margin | 57.17% |
| Net Profit Margin | -109.93% |
| Debt/Equity Ratio | 0% |
How did 600381 perform over the long term?
See historical performance and comparison